Frontlight ResearchEarly access
Trial site
University Malaya Medical Centre
- 17running trials
- 10closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Obesity7 trials
- Type 2 diabetes7 trials
- Chronic kidney disease4 trials
- Ulcerative colitis3 trials
- Heart failure2 trials
- Lung cancer2 trials
- Peripheral artery disease2 trials
- Turner syndrome2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- IgA nephropathy1 trial
- Stroke1 trial
- Phase
- Phase 322 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Completed9 trials
- Active, not recruiting7 trials
- Recruiting7 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Novo Nordisk A/S19 trials
- Eli Lilly and Company4 trials
- Biogen1 trial
- Bristol-Myers Squibb1 trial
- CSL Behring1 trial
- and 1 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Chronic kidney disease2 recruiting
- Type 2 diabetes2 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Lung cancer1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Withdrawn
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026